Fintel reports that on February 20, 2025, B. Riley Securities initiated coverage of Electromed (NYSEAM:ELMD) with a Buy ...
B. Riley analyst Kyle Bauser initiated coverage of Electromed (ELMD) with a Buy rating and $38 price target Electromed is a profitable, ...
Electromed (EMED) stock was launched by B. Riley with a Buy recommendation, based on its potential to become a takeover target. Read more here.
StockNews.com lowered shares of Electromed (NYSE:ELMD – Free Report) from a strong-buy rating to a buy rating in a report issued on Wednesday morning. Electromed Stock Performance NYSE ELMD opened at ...
Kathleen Skarvan, a director at Electromed, Inc. (NYSE:ELMD), recently reported significant stock transactions involving the company's common stock. The transactions come as the stock has shown ...
NEW PRAGUE, Minn., February 11, 2025--Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial ...
Three of JSMD's underlying holdings with notable upside to their analyst target prices are Electromed, Inc. (Symbol: ELMD), GUARDIAN PHARMACY (Symbol: GRDN), and ePlus Inc (Symbol: PLUS).
Facing a Shift in Market Trends?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results